成都倍特药业股份有限公司

Chinese pharmaceutical company headquartered in the Chengdu high-tech zone in Sichuan, combining drug research, manufacturing and sales as a high-tech enterprise, with more than twenty subsidiaries and branches and over 5,000 staff. Concentrates on innovative drugs, specialty active pharmaceutical ingredients, high-end generics and new drug delivery systems, running an integrated chain from intermediates and active ingredients through to finished products across chemical drugs including radiopharmaceuticals, biologics and Chinese medicines. Sells more than 200 formulation products in oncology and immunology, respiratory, haematology, obstetrics and gynaecology, anti-infectives, contrast media, cardio-cerebrovascular disease, musculoskeletal and psychiatric and neurological medicine through a nationwide network extending overseas, and was named among China's top hundred pharmaceutical manufacturers for seven consecutive years from 2013 to 2020.